Oncology Drug Discovery & Development Market Size, Share & Trends Analysis Report By Drug/Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Others), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Leukemia Cancer, Lymphoma Cancer, Ovarian Cancer, Others), By Stage, By Region, And By Segment Forecasts, 2025-2034
Oncology Drug Discovery & Development Market Size is predicted to witness a 18.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increase in global cancer prevalence is a major driver for the oncology drug discovery and development market. Advancements in cancer biology, genomics, and immunology are driving the oncology drug discovery and development market. Nort...
Report ID: 2211 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Vascular Disrupting Agents Market Size, Share & Trends Analysis Report By Indication, By Therapeutic Area (Hematological Malignancies, Solid Tumors), By Product, By Molecule, By Therapy, By Route of Administration, By Region, And By Segment Forecasts, 2029-2034.
Vascular Disrupting Agents Market Size is predicted to grow at an 10% CAGR during the forecast period for 2029-2034. Vascular disrupting agents (VDAs) are a novel family of medications that target the existing tumour vasculature and cause tumour necrosis. As the world's population has aged, so has the global burden of cancer morbidity and mortality. Cancer is the primary or second leading cause of death among persons under the age of 70 ...
Report ID: 1299 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Hospital Energy Management Solutions Market Size, Share & Trends Analysis Report By Product (Equipment, Control System), By Application (Hospital Logistics Power, Hospital Emergency Logistics Power, Others), By Region, And By Segment Forecasts, 2025-2034
Hospital Energy Management Solutions Market Size predicted to reach represent a 8.5% CAGR during the forecast period for 2025-2034. Hospital Energy Management Systems (HEMS) optimize energy use in healthcare facilities, aiming to cut operational costs, boost patient comfort, and lessen environmental impact. These systems integrate advanced technology and strategies to manage energy consumption efficiently. Key elements include energy monitorin...
Report ID: 2349 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
ATMPs Consulting Market Size, Share & Trends Analysis Report By Phase (Early-Stage Development, Clinical Development, Commercialization), By Type (Gene therapy medicinal products, Somatic cell medicinal products, Tissue-engineered medicinal products), By Region, And By Segment Forecasts, 2025-2034
ATMPs Consulting Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2025-2034. Advanced therapy medical products (ATMPs) are human medicines based on genes, tissues, or cells. They provide new and novel therapeutic options for ailments and injuries. ATMPs primarily target diseases with significant unmet medical needs. The introduction of ATMPs has altered the pharmaceutical industry as well as the illness treatment la...
Report ID: 2152 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Immunoturbidimetry Reagents Market Size, Share & Trends Analysis Report By Type (Common Immune Turbidimetric Reagent, Latex Enhanced Immune Turbidimetric Reagent), By Application (Glycated hemoglobin, Retinol Binding Protein, C-Reactive Protein, Anti-streptococcal hemolysin
Immunoturbidimetry Reagents Market Size is predicted to represent a 7.2% CAGR during the forecast period for 2025-2034. Immunoturbidimetry (IT) is a valuable diagnostic tool in clinical chemistry. It's utilized to find blood proteins that aren't detectable using typical clinical chemistry methods or the antigen-antibody reaction. Immunoturbidimetry is based on antigen-antibody interactions that are specific and sensitive. Each antibody recogni...
Report ID: 2200 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market Size, Share & Trends Analysis Report, By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others), By Region, Forecasts, 2025-2034
Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market Size is predicted to expand at a 9.8% CAGR during the forecast period for 2025-2034. The surge in cancer prevalence and the trend toward personalized treatment serve as the primary drivers of market expansion. The quest for novel therapeutic targets is imperative to offer improved treatment options for the escalating number of cancer cases. TROP2 has eme...
Report ID: 2493 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Live biotherapeutic/Microbiome Based Therapeutics Market Size, Share & Trends Analysis Report By Product (VOWST (SER-109), REBYOTA, Visbiome, Other Pipeline Products), By Route of Administration (Oral Therapeutics, Rectal Therapeutics), By Target Disease Indication (Recurrent C. Difficile Infection, Dietary Management of Microbial Imbalance, Other Indications), By Distribution Channel, By End User, By Region, And Segment Forecasts, 2025-2034
Live biotherapeutic/Microbiome Based Therapeutics Market Size is valued at USD 73.25 Bn in 2024 and is predicted to reach USD 142.81 Bn by the year 2034 at a 7.04% CAGR during the forecast period for 2025-2034. A live microbe is utilized in a Live Biotherapeutic product to treat, prevent, or cure a disease. Microorganisms that may be beneficial to health have been discovered as the human ...
Report ID: 1300 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Lipid-Nanoparticle Based Genomic Medicines Market Size, Share & Trends Analysis Report By Products (D2C Gut Health Test, Probiotic Supplements, Personalized Nutrition, Microbiome Modulators, Ingredients, Medical Foods, Therapeutics), By End-User (Adult, Maternal, Infant), By Region, And By Segment Forecasts, 2025-2034
Lipid-Nanoparticle Based Genomic Medicines Market Size is valued at USD 2.58 Bn in 2024 and is predicted to reach USD 38.04 Bn by the year 2034 at a 31.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The shift towards customized medicine is driving the lipid-nanoparticle-based genomic medicines market. The rise in mRNA-based therapeutics, enabled by lipid nanoparticles, is a signif...
Report ID: 2380 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Somatropin Market Size, Share & Trends Analysis Report By Applications (Chronic Renal Insufficiency, Growth Hormone Deficiency, Turners Syndrome, Prader-Willi Syndrome, Idiopathic Short Stature, and Noonan Syndrome), By Distribution Channel, Region And Segment Forecasts, 2025-2034
Somatropin Market is expected to grow at a 7.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: One factor driving the growing demand for somatropin is the increasing frequency of growth hormone deficiency diagnoses in both adults and children, while another is the improvement in medical diagnostic technology, which permits earlier and more precise identification of growth hormone deficie...
Report ID: 1111 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Neoantigen Cancer Vaccine Market Size, Share & Trends Analysis Report By Product (Personalized and Off-The-Shelf Neoantigen Vaccines), By Neovaccine Type, By Therapeutic Area, By Therapy Type, Region And Segment Forecasts, 2025-2034
Global Neoantigen Cancer Vaccine Market is expected to grow at a 20.0% CAGR during the forecast period for 2025-2034. Neoantigen Cancer Vaccines are vaccines that assist in boosting the immune system by using a single or several antigens. The antigens generally consist of several peptides or proteins. Neoantigens are a mutated or a new type of antigen present only in cancer cells and not in rest normal cells. Neoantigen Cancer Vaccines stimulate...
Report ID: 1117 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Pharmaceuticals